How can we use anthracylines in the management of newly diagnosed metastatic breast cancer patients overexpressing HER-2?

被引：1
|
作者：
Harputluoglu, H. [1 ]
Altundag, K. [1 ]
机构：
[1] Hacettepe Univ, Inst Oncol, Dept Med Oncol, Ankara, Turkey
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷 / 06期
关键词：
D O I：
10.1093/annonc/mdn152
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1203 / 1203
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of trastuzumab as a single agent in heavily pretreated patients with HER-2/NEU-overexpressing metastatic breast cancer
    Sawaki, M
    Ito, Y
    Tada, K
    Mizunuma, N
    Takahashi, S
    Horikoshi, N
    Kasumi, F
    Akiyama, F
    Sakamoto, G
    Imai, T
    Nakao, A
    Hatake, K
    TUMORI JOURNAL, 2004, 90 (01): : 40 - 43
  • [22] Increased b1 integrin expression is a predictor of trastuzumab resistance in HER-2 overexpressing metastatic breast cancer patients
    Thoms, J.
    Sabri, S.
    Lesniak, D.
    Lai, R.
    Deschennes, J.
    Mackey, J.
    Murray, D.
    Abdulkarim, B.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S92 - S92
  • [23] The antitumor immune response in HER-2 positive, metastatic breast cancer patients
    Zorica D Juranic
    Zora Neskovic-Konstantinovic
    Tatjana P Stanojkovic
    Zeljko Zizak
    Tatjana Srdic
    Nevenka Stanojevic-Bakic
    Dusanka Milosevic
    Danica Jovanovic
    Journal of Translational Medicine, 3
  • [24] The antitumor immune response in HER-2 positive, metastatic breast cancer patients
    Juranic, ZD
    Neskovic-Konstantinovic, Z
    Stanojkovic, TP
    Zizak, Z
    Srdic, T
    Stanojevic-Bakic, N
    Milosevic, D
    Jovanovic, D
    JOURNAL OF TRANSLATIONAL MEDICINE, 2005, 3 (1)
  • [25] How We Treat HER2-Positive Metastatic Breast Cancer
    Komaranchath, Ashok S.
    Mathew, Aju
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2021, 42 (04) : 370 - 375
  • [26] Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer
    Azeem Saleem
    Graham E Searle
    Laura M Kenny
    Mickael Huiban
    Kasia Kozlowski
    Adam D Waldman
    Laura Woodley
    Carlo Palmieri
    Charles Lowdell
    Tomomi Kaneko
    Philip S Murphy
    Mike R Lau
    Eric O Aboagye
    Raoul C Coombes
    EJNMMI Research, 5
  • [27] Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer
    Saleem, Azeem
    Searle, Graham E.
    Kenny, Laura M.
    Huiban, Mickael
    Kozlowski, Kasia
    Waldman, Adam D.
    Woodley, Laura
    Palmieri, Carlo
    Lowdell, Charles
    Kaneko, Tomomi
    Murphy, Philip S.
    Lau, Mike R.
    Aboagye, Eric O.
    Coombes, Raoul C.
    EJNMMI RESEARCH, 2015, 5
  • [28] Pegylated liposomal doxorubicin and trastuzumab in HER-2 overexpressing metastatic breast cancer: A multicenter phase II trial
    Chia, Stephen
    Clemons, Mark
    Martin, Lee-Ann
    Rodgers, Angela
    Gelmon, Karen
    Pond, Gregory R.
    Panasci, Lawrence
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 2773 - 2778
  • [29] PTEN expression as a predictor for the response to trastuzumab-based therapy in Her-2 overexpressing metastatic breast cancer
    Gschwantler-Kaulich, Daphne
    Tan, Yen Y.
    Fuchs, Eva-Maria
    Hudelist, Gernot
    Koestler, Wolfgang J.
    Reiner, Angelika
    Leser, Carmen
    Salama, Mohamed
    Attems, Johannes
    Deutschmann, Christine
    Zielinski, Christoph C.
    Singer, Christian F.
    PLOS ONE, 2017, 12 (03):
  • [30] HER-2 Protein Overexpressing Breast Cancer Without Gene Amplification Shows Higher Hormone Receptor Expression Than HER-2 Protein Overexpressing Breast Cancer With Gene Amplification
    Koo, Ja Seung
    Jung, Woohee
    Yang, Woo Ick
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2011, 19 (04) : 425 - 432
12345